Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 9.72
+0.07 (0.73%)
Jun 9, 2026, 3:00 PM CST
SHA:600380 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,222 | 21,130 | 21,122 | 23,173 | 21,061 | 24,015 | |
Market Cap Growth | -11.94% | 0.04% | -8.85% | 10.03% | -12.30% | -10.62% |
Enterprise Value | 15,366 | 18,996 | 20,222 | 22,884 | 20,341 | 24,185 |
Last Close Price | 9.65 | 11.55 | 11.09 | 12.02 | 10.76 | 12.08 |
PE Ratio | 13.26 | 15.82 | 15.23 | 16.06 | 14.02 | 18.08 |
Forward PE | 12.06 | 13.97 | 13.09 | 14.25 | 12.76 | 17.03 |
PS Ratio | 1.16 | 1.39 | 1.35 | 1.39 | 1.23 | 1.51 |
PB Ratio | 0.70 | 0.87 | 0.90 | 1.02 | 0.96 | 1.19 |
P/TBV Ratio | 1.22 | 1.55 | 1.60 | 1.86 | 1.80 | 2.23 |
P/FCF Ratio | 5.31 | 6.76 | 7.95 | 8.28 | 7.44 | 23.06 |
P/OCF Ratio | 4.31 | 5.43 | 5.81 | 5.90 | 5.30 | 9.37 |
EV/Sales Ratio | 1.03 | 1.25 | 1.30 | 1.38 | 1.19 | 1.52 |
EV/EBITDA Ratio | 4.13 | 5.04 | 5.22 | 5.96 | 5.52 | 7.64 |
EV/EBIT Ratio | 5.28 | 6.36 | 6.54 | 8.13 | 7.07 | 9.40 |
EV/FCF Ratio | 4.74 | 6.08 | 7.61 | 8.18 | 7.19 | 23.22 |
Debt / Equity Ratio | 0.16 | 0.18 | 0.23 | 0.27 | 0.25 | 0.17 |
Debt / EBITDA Ratio | 1.05 | 1.15 | 1.41 | 1.58 | 1.47 | 1.08 |
Debt / FCF Ratio | 1.20 | 1.40 | 2.07 | 2.19 | 1.92 | 3.32 |
Net Debt / Equity Ratio | -0.44 | -0.48 | -0.43 | -0.44 | -0.43 | -0.42 |
Net Debt / EBITDA Ratio | -2.92 | -3.14 | -2.58 | -2.62 | -2.59 | -2.67 |
Net Debt / FCF Ratio | -3.32 | -3.78 | -3.77 | -3.59 | -3.37 | -8.11 |
Asset Turnover | 0.42 | 0.43 | 0.43 | 0.46 | 0.51 | 0.54 |
Inventory Turnover | 2.42 | 2.38 | 2.31 | 2.53 | 2.75 | 2.96 |
Quick Ratio | 2.03 | 2.33 | 2.15 | 2.12 | 2.06 | 1.80 |
Current Ratio | 2.37 | 2.62 | 2.48 | 2.42 | 2.38 | 2.07 |
Return on Equity (ROE) | 11.52% | 12.00% | 12.96% | 12.77% | 13.72% | 13.26% |
Return on Assets (ROA) | 5.11% | 5.25% | 5.36% | 4.88% | 5.38% | 5.43% |
Return on Invested Capital (ROIC) | 18.98% | 19.60% | 19.85% | 18.47% | 19.90% | 21.54% |
Return on Capital Employed (ROCE) | 11.10% | 11.20% | 11.70% | 10.60% | 11.10% | 11.80% |
Earnings Yield | 7.63% | 6.32% | 6.57% | 6.23% | 7.13% | 5.53% |
FCF Yield | 18.84% | 14.79% | 12.58% | 12.08% | 13.44% | 4.34% |
Dividend Yield | 2.28% | 1.91% | 1.80% | 1.50% | 1.67% | 1.24% |
Payout Ratio | 34.02% | 33.48% | 33.76% | 33.33% | 25.89% | 28.79% |
Buyback Yield / Dilution | 4.36% | 2.36% | 1.30% | -0.07% | 2.07% | 0.97% |
Total Shareholder Return | 6.58% | 4.26% | 3.10% | 1.42% | 3.75% | 2.21% |